Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6694 | 1380 | 32.4 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2030 | 4913 | CARDIOPULMONARY BYPASS//APROTININ//PERFUSION-UK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | APROTININ | Author keyword | 135 | 42% | 18% | 252 |
2 | TRANEXAMIC ACID | Author keyword | 28 | 21% | 8% | 115 |
3 | EPSILON AMINOCAPROIC ACID | Author keyword | 14 | 39% | 2% | 28 |
4 | ANTIFIBRINOLYTIC AGENTS | Author keyword | 12 | 45% | 2% | 21 |
5 | ANTIFIBRINOLYTICS | Author keyword | 12 | 35% | 2% | 28 |
6 | POLYPEPTIDES APROTININ | Author keyword | 9 | 83% | 0% | 5 |
7 | AMINOCAPROIC ACID | Author keyword | 6 | 30% | 1% | 16 |
8 | AMICAR EPSILON AMINOCAPROIC ACID | Author keyword | 6 | 100% | 0% | 4 |
9 | ANTIFIBRINOLYTIC AGENT | Author keyword | 4 | 47% | 1% | 7 |
10 | LOW DOSE APROTININ | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | APROTININ | 135 | 42% | 18% | 252 | Search APROTININ | Search APROTININ |
2 | TRANEXAMIC ACID | 28 | 21% | 8% | 115 | Search TRANEXAMIC+ACID | Search TRANEXAMIC+ACID |
3 | EPSILON AMINOCAPROIC ACID | 14 | 39% | 2% | 28 | Search EPSILON+AMINOCAPROIC+ACID | Search EPSILON+AMINOCAPROIC+ACID |
4 | ANTIFIBRINOLYTIC AGENTS | 12 | 45% | 2% | 21 | Search ANTIFIBRINOLYTIC+AGENTS | Search ANTIFIBRINOLYTIC+AGENTS |
5 | ANTIFIBRINOLYTICS | 12 | 35% | 2% | 28 | Search ANTIFIBRINOLYTICS | Search ANTIFIBRINOLYTICS |
6 | POLYPEPTIDES APROTININ | 9 | 83% | 0% | 5 | Search POLYPEPTIDES++APROTININ | Search POLYPEPTIDES++APROTININ |
7 | AMINOCAPROIC ACID | 6 | 30% | 1% | 16 | Search AMINOCAPROIC+ACID | Search AMINOCAPROIC+ACID |
8 | AMICAR EPSILON AMINOCAPROIC ACID | 6 | 100% | 0% | 4 | Search AMICAR+EPSILON+AMINOCAPROIC+ACID | Search AMICAR+EPSILON+AMINOCAPROIC+ACID |
9 | ANTIFIBRINOLYTIC AGENT | 4 | 47% | 1% | 7 | Search ANTIFIBRINOLYTIC+AGENT | Search ANTIFIBRINOLYTIC+AGENT |
10 | LOW DOSE APROTININ | 4 | 75% | 0% | 3 | Search LOW+DOSE+APROTININ | Search LOW+DOSE+APROTININ |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HIGH DOSE APROTININ | 231 | 75% | 12% | 167 |
2 | APROTININ | 63 | 25% | 16% | 216 |
3 | EPSILON AMINOCAPROIC ACID | 63 | 37% | 10% | 134 |
4 | DOSE APROTININ | 51 | 64% | 4% | 50 |
5 | TRASYLOL | 45 | 62% | 3% | 47 |
6 | BLOOD LOSS | 41 | 13% | 22% | 304 |
7 | LOW DOSE APROTININ | 40 | 77% | 2% | 27 |
8 | TRANEXAMIC ACID | 26 | 16% | 11% | 148 |
9 | RISK CARDIAC SURGERY | 20 | 63% | 1% | 20 |
10 | ANTIFIBRINOLYTIC AGENTS | 13 | 62% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The current place of tranexamic acid in the management of bleeding | 2015 | 2 | 13 | 46% |
Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis | 2015 | 1 | 26 | 81% |
Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials | 2004 | 181 | 16 | 88% |
Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery | 2007 | 136 | 133 | 90% |
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints | 1999 | 277 | 84 | 81% |
Drug therapy: Prevention and treatment of major blood loss | 2007 | 148 | 77 | 47% |
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion | 2007 | 86 | 220 | 72% |
Tranexamic Acid A Review of its Use in the Treatment of Hyperfibrinolysis | 2012 | 43 | 143 | 50% |
Universal definition of perioperative bleeding in adult cardiac surgery | 2014 | 12 | 30 | 33% |
Hemostatic drugs | 1998 | 267 | 73 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EDMUND COHEN VASC | 2 | 38% | 0.4% | 5 |
2 | EMORY HEALTHCARE | 2 | 29% | 0.4% | 5 |
3 | PAEDIAT CARDIOL CONGENITAL HEART DEFECTS | 2 | 33% | 0.3% | 4 |
4 | CARDIAC ANESTHESIA INTENS CARE | 2 | 22% | 0.4% | 6 |
5 | BIOCHEM CENT S | 1 | 100% | 0.1% | 2 |
6 | BLOOD COAGULAT DISORDER | 1 | 100% | 0.1% | 2 |
7 | BRITISH HEART FDN UNIT CARDIOVASC MED | 1 | 100% | 0.1% | 2 |
8 | MED CARDIOTHORAC ANESTHESIOL CRIT CARE | 1 | 50% | 0.1% | 2 |
9 | MEDBHF CARDIOVASC MED UNIT | 1 | 100% | 0.1% | 2 |
10 | INFECTOL DERMATOL | 1 | 40% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000295248 | HEPARIN RESISTANCE//ACTIVATED CLOTTING TIME//ACTIVATED COAGULATION TIME |
2 | 0.0000200952 | DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN |
3 | 0.0000153889 | CARDIOPULMONARY BYPASS//PERFUSION-UK//MODIFIED ULTRAFILTRATION |
4 | 0.0000117727 | AUTOTRANSFUSION//AUTOLOGOUS BLOOD DONATION//AUTOLOGOUS TRANSFUSION |
5 | 0.0000105026 | MASSIVE TRANSFUSION//THROMBOELASTOMETRY//THROMBOELASTOGRAPHY |
6 | 0.0000082720 | POSTREPERFUSION SYNDROME//POST REPERFUSION SYNDROME//VENO VENOUS BYPASS |
7 | 0.0000079046 | ALLIED MED SCI SUMA KU//MED FUKUSHIMA KU//TARUMI KU |
8 | 0.0000077934 | PATIENT BLOOD MANAGEMENT//TRANSFUSION//BLOOD TRANSFUSION |
9 | 0.0000062383 | RIMANTADINE//AMANTADINE HCL//MEMANTINE HYDROCHLORIDE |
10 | 0.0000061775 | RFVIIA//RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA |